These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 29938917)
1. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine. Yang B; Chen Y; Shi J Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917 [TBL] [Abstract][Full Text] [Related]
2. Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms. Singh RK; Patel KD; Leong KW; Kim HW ACS Appl Mater Interfaces; 2017 Mar; 9(12):10309-10337. PubMed ID: 28274115 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Lee JE; Lee N; Kim T; Kim J; Hyeon T Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274 [TBL] [Abstract][Full Text] [Related]
4. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine. Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647 [TBL] [Abstract][Full Text] [Related]
5. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy. Murugan B; Krishnan UM Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004 [TBL] [Abstract][Full Text] [Related]
6. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics. Zhang W; Liu M; Liu A; Zhai G Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244 [TBL] [Abstract][Full Text] [Related]
7. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine. Zhou Y; Han X; Jing X; Chen Y Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530 [TBL] [Abstract][Full Text] [Related]
8. Shape matters when engineering mesoporous silica-based nanomedicines. Hao N; Li L; Tang F Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852 [TBL] [Abstract][Full Text] [Related]
9. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Samykutty A; Grizzle WE; Fouts BL; McNally MW; Chuong P; Thomas A; Chiba A; Otali D; Woloszynska A; Said N; Frederick PJ; Jasinski J; Liu J; McNally LR Biomaterials; 2018 Nov; 182():114-126. PubMed ID: 30118979 [TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579 [TBL] [Abstract][Full Text] [Related]
12. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications. Liu J; Liu T; Pan J; Liu S; Lu GQM Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224 [TBL] [Abstract][Full Text] [Related]
13. A versatile theranostic nanoplatform based on mesoporous silica. Zhang Y; Cheng J; Li N; Wang R; Huang G; Zhu J; He D Mater Sci Eng C Mater Biol Appl; 2019 May; 98():560-571. PubMed ID: 30813059 [TBL] [Abstract][Full Text] [Related]
14. A High-Sensitivity and Low-Power Theranostic Nanosystem for Cell SERS Imaging and Selectively Photothermal Therapy Using Anti-EGFR-Conjugated Reduced Graphene Oxide/Mesoporous Silica/AuNPs Nanosheets. Chen YW; Liu TY; Chen PJ; Chang PH; Chen SY Small; 2016 Mar; 12(11):1458-68. PubMed ID: 26814978 [TBL] [Abstract][Full Text] [Related]
15. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures. Chen Y; Chen H; Shi J Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014 [TBL] [Abstract][Full Text] [Related]
16. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer. Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153 [TBL] [Abstract][Full Text] [Related]
17. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms. Yang B; Chen Y; Shi J Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052 [TBL] [Abstract][Full Text] [Related]